Published 9 March 2009, doi:10.1136/bmj.b736
Cite this as: BMJ 2009;338:b736

Feature

Research Transparency

Industry attack on academics

¹ London

An apparently uncontroversial study of potential industry influence on sponsored drug trials resulted in the authors facing accusations of misconduct, Jonathan Gornall reports

The first 150 words of the full text of this article appear below.

It began with the publication of a research letter,¹ the third paper from a group of researchers in a series concerned with the accountability and transparency of randomised trials.^{2 3} It led not to debate through the normal scientific forums but to a series of public attacks by a national drug industry body on the integrity of the researchers, culminating in a formal accusation that they were guilty of scientific misconduct.

JAMA published "Constraints on publication rights in industry-related clinical trials" in April 2006. The paper was based on a study of 44 industry initiated randomised trials approved by the scientific and ethics committees for Copenhagen and Frederiksberg in Denmark in 1994-5 and published in 2004.¹

The researchers, of whom four worked for the Nordic Cochrane Centre in Denmark and two for the Centre for Statistics in Medicine in Oxford, had chosen to work with the Danish material because they were . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study

Julie Pildal, An-Wen Chan, Asbjørn Hróbjartsson, Elisabeth Forfang, Douglas G Altman, and Peter C Gøtzsche
BMJ 2005 330: 1049. [Abstract] [Full Text] [PDF]

Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1)

Karmela Krleza-Jeric, An-Wen Chan, Kay Dickersin, Ida Sim, Jeremy Grimshaw, Christian Gluud for the Ottawa Group
BMJ 2005 330: 956-958. [Extract] [Full Text] [PDF]

BMJ statistical errors

Tim J Cole, Douglas Altman, Deborah Ashby, Mike Campbell, Jonathan Deeks, Stephen Evans, Hazel Inskip, Julie Morris, and Gordon Murray
BMJ 2004 329: 462. [Extract] [Full Text]

Efficacy and safety of antidepressants for children and adolescents

Jon N Jureidini, Christopher J Doecke, Peter R Mansfield, Michelle M Haby, David B Menkes, and Anne L Tonkin
BMJ 2004 328: 879-883. [Extract] [Full Text] [PDF]

Online poll

Find out more on doc2doc >>